{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T10:36:56Z","timestamp":1756636616984,"version":"3.41.2"},"reference-count":11,"publisher":"Japanese Society of Internal Medicine","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,8,1]]},"DOI":"10.2169\/internalmedicine.4864-24","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T17:11:47Z","timestamp":1738948307000},"page":"2415-2417","source":"Crossref","is-referenced-by-count":1,"title":["Nicorandil-induced Isolated Abducens Nerve Palsy"],"prefix":"10.2169","volume":"64","author":[{"given":"Fumiya","family":"Kutsuna","sequence":"first","affiliation":[{"name":"Department of Neurology, Nagao Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuyoshi","family":"Setsu","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, Nagao Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumitada","family":"Hattori","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, Nagao Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"doi-asserted-by":"crossref","unstructured":"1. Roland E. Safety profile of an anti-anginal agent with potassium channel opening activity: an overview. Eur Heart J 14 (Suppl B): 48-52, 1993.","key":"1","DOI":"10.1093\/eurheartj\/14.suppl_B.48"},{"doi-asserted-by":"crossref","unstructured":"2. Horinaka S, Yabe A, Yagi H, et al.; the JCAD Study Investigators. Effects of nicorandil on cardiovascular events in patients with coronary artery disease in the Japanese Coronary Artery Disease (JCAD) study. Circ J 74: 503-509, 2010.","key":"2","DOI":"10.1253\/circj.CJ-09-0649"},{"doi-asserted-by":"crossref","unstructured":"3. Walker A, McMurray J, Stewart S, et al. Economic evaluation of the impact of nicorandil in angina (IONA) trial. Heart 92: 619-624, 2006.","key":"3","DOI":"10.1136\/hrt.2003.026385"},{"doi-asserted-by":"crossref","unstructured":"4. Dunn N, Freemantle S, Pearce G, Wilton LV, Mann RD. Safety profile of nicorandil - prescription-event monitoring (PEM) study. Pharmacoepidemiol Drug Saf 8: 197-205, 1999.","key":"4","DOI":"10.1002\/(SICI)1099-1557(199905\/06)8:3<197::AID-PDS422>3.0.CO;2-T"},{"doi-asserted-by":"crossref","unstructured":"5. Malde S, Wilson A. Rectal ulceration caused by the anti-anginal nicorandil: case report of a preventable complication. Patient Saf Surg 4: 10, 2010.","key":"5","DOI":"10.1186\/1754-9493-4-10"},{"doi-asserted-by":"crossref","unstructured":"6. Ahmed LA. Nicorandil: a drug with ongoing benefits and different mechanisms in various diseased conditions. Indian J Pharmacol 51: 296-301, 2019.","key":"6","DOI":"10.4103\/ijp.IJP_298_19"},{"doi-asserted-by":"crossref","unstructured":"7. Jeong SH, Kim H. Acute intractable headache and oculomotor nerve palsy associated with nicorandil: a case report. Am J Emerg Med 35: 1988.e3-1988.e5, 2017.","key":"7","DOI":"10.1016\/j.ajem.2017.10.006"},{"doi-asserted-by":"crossref","unstructured":"8. Cadman-Davies MG, Chandegra R, Scotcher SM, Prasad N. Nicorandil induced ophthalmoplegic migraine. JRSM Short Rep 3: 41, 2012.","key":"8","DOI":"10.1258\/shorts.2011.011177"},{"doi-asserted-by":"crossref","unstructured":"9. Trechot P, Conart JB, Petitpain N, Trechot F. Severe headaches and 3rd or 6th nerve palsy associated with nicorandil: a hypothesis. Am J Emerg Med 36: 1500-1501, 2018.","key":"9","DOI":"10.1016\/j.ajem.2017.12.001"},{"doi-asserted-by":"publisher","unstructured":"10. Clement A, Guo S, Jansen-Olesen I, Christensen SL. ATP-sensitive potassium channels in migraine: translational findings and therapeutic potential. Cells 11: 2406, 2022.","key":"10","DOI":"10.3390\/cells11152406"},{"doi-asserted-by":"crossref","unstructured":"11. Elder C, Hainline C, Galetta SL, Balcer LJ, Rucker JC. Isolated abducens nerve palsy: update on evaluation and diagnosis. Curr Neurol Neurosci Rep 16: 69, 2016.","key":"11","DOI":"10.1007\/s11910-016-0671-4"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/15\/64_4864-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T04:16:40Z","timestamp":1754108200000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/15\/64_4864-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":11,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4864-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"article-number":"4864-24"}}